Menu

Home / For Visitors / 2024 Exhibitor List / FORESEE PHARMACEUTICALS CO., LTD.

FORESEE PHARMACEUTICALS CO., LTD.

Area: Pharmaceutical and Medical Devices

Booth No: L226

Website: https://www.foreseepharma.com/zh-tw/index

Exhibitor Profile

Foresee Pharmaceuticals Co., Ltd. is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO).
a. CAMCEVI (FP-001): for prostate cancer/CPP, CAMCEVI 42 mg, is now approved in the U.S., Canada, EU and Taiwan, and launched in the U.S. in 2022.
b. FP-025: an MMP-12 inhibitor, for cardiac sarcoidosis. A Phase 2a trial of FP-025 in allergic asthma has been completed with positive outcomes.
c. FP-045: a ALDH2 activator, for Fanconi Anemia/PH-ILD.

Brands

CAMCEVI 42 mg injection emulsion

Exhibit Products

CAMCEVI

Exhibitors you may be interested in

Highest Rated

TOP